Insights

Innovative Research Focus ALSP Inc. is engaged in cutting-edge neurodegenerative disease research, developing small molecule drugs targeting proteases involved in conditions such as traumatic brain injury and Alzheimer's disease, presenting opportunities for collaborations in advanced drug development technologies.

Emerging Market Potential With an expanding portfolio targeting multiple neurodegenerative disorders, ALSP Inc. is positioned to benefit from a growing demand for novel therapies in neurodegeneration, creating avenues for pharmaceutical partners and investors seeking innovative treatments.

Limited Financial Data As a privately held company with undisclosed funding levels, there are opportunities for engagement with potential investors or partners interested in early-stage biotech ventures focused on high-impact neurological diseases.

Technology Stack Utilization The company's use of modern web technologies indicates an operational inclination towards innovative digital solutions, which could facilitate collaborations in tech-enabled drug discovery or data analytics partnerships.

Focused Specialty Niche Specializing in neuroprotease targeting for neurodegenerative diseases, ALSP Inc. represents a niche opportunity for co-development or licensing agreements with organizations aiming to expand their portfolio in neurological therapeutics.

ALSP, Inc. Tech Stack

ALSP, Inc. uses 8 technology products and services including SiteCatalyst, Google Fonts API, React, and more. Explore ALSP, Inc.'s tech stack below.

  • SiteCatalyst
    Analytics
  • Google Fonts API
    Font Scripts
  • React
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Lua
    Programming Languages
  • Plyr
    Video Players
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

ALSP, Inc.'s Email Address Formats

ALSP, Inc. uses at least 1 format(s):
ALSP, Inc. Email FormatsExamplePercentage
FLast@alspinc.comJDoe@alspinc.com
33%
First.Last@alspinc.comJohn.Doe@alspinc.com
17%
FLast@alspinc.comJDoe@alspinc.com
33%
First.Last@alspinc.comJohn.Doe@alspinc.com
17%

Frequently Asked Questions

Where is ALSP, Inc.'s headquarters located?

Minus sign iconPlus sign icon
ALSP, Inc.'s main headquarters is located at 7514 Girard Avenue, Ste. 1-301 La Jolla, CA 92037-5199, US. The company has employees across 2 continents, including North AmericaEurope.

What is ALSP, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact ALSP, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ALSP, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ALSP, Inc.'s official website is alspinc.com and has social profiles on LinkedInCrunchbase.

What is ALSP, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
ALSP, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ALSP, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, ALSP, Inc. has approximately 3 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. J.Principal: M. A.. Explore ALSP, Inc.'s employee directory with LeadIQ.

What industry does ALSP, Inc. belong to?

Minus sign iconPlus sign icon
ALSP, Inc. operates in the Biotechnology Research industry.

What technology does ALSP, Inc. use?

Minus sign iconPlus sign icon
ALSP, Inc.'s tech stack includes SiteCatalystGoogle Fonts APIReactjQueryLuaPlyrOpenRestyNginx.

What is ALSP, Inc.'s email format?

Minus sign iconPlus sign icon
ALSP, Inc.'s email format typically follows the pattern of FLast@alspinc.com. Find more ALSP, Inc. email formats with LeadIQ.
ALSP, Inc.

ALSP, Inc.

Biotechnology ResearchUnited States2-10 Employees

ALSP Inc. (American Life Science Pharmaceuticals, Inc.), is a privately held company based in San Diego, California,  developing new small molecule drugs for treating neurodegenerative disease initially focused on traumatic brain injury and Alzheimer's disease. Our approach is to identify key enzymes in the brain, called proteases, which produce biologically active peptides, proteins or processes that are thought to underlie the disease. We then use those enzymes as targets for screening compounds that inhibit these proteases and thereby prevent the harmful effect caused by these peptides, proteins and processes to treat the disease.

By using this innovative process, our goal is to create and advance highly-effective drug development strategies and products for treating not only traumatic brain injury and Alzheimer's disease,  but other Neurodegenerative Conditions such as Huntington's disease, Parkinson's disease and MS, and recover quality of life for those patients and their families.

Section iconCompany Overview

Headquarters
7514 Girard Avenue, Ste. 1-301 La Jolla, CA 92037-5199, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    ALSP, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    ALSP, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.